Actively Recruiting

Phase Not Applicable
Age: 40Years - 75Years
All Genders
ID05573490

Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study

Led by Indiana University · Updated on 2026-05-06

60

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

I

Indiana University

Lead Sponsor

A

Alzheimer's Association

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of combining computerized cognitive training with Tai Chi- Qi Gong exercise in people diagnosed with Early-Onset Alzheimer's Disease (EOAD). This study aims to gather preliminary data on whether this lifestyle intervention can improve thinking skills, daily functioning, and mood. The study also explores how individual characteristics might influence the benefits from the training. Participants will be randomly assigned to one of two groups for 14 weeks: one group will receive cognitive training using the BrainHQ mobile app alongside Tai Chi- Qi Gong exercise sessions, while the other group will use BrainHQ's brain games and perform stretching exercises. The cognitive training involves about 45 minutes per session, 4 to 5 times per week, and the Tai Chi or stretching sessions occur twice per week for around 30 minutes each. During the study, participants will undergo cognitive, functional, and mood assessments before the intervention, immediately after the 14-week intervention, and again 6 months later. These evaluations include computerized memory and executive function tests, self-reported questionnaires on cognition, depression, quality of life, stress, and social support. The study uses remote assessments and monitors participants' progress over several months to understand the short- and long-term effects of the lifestyle interventions.

CONDITIONS

Brief Title

Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study

Who Can Participate

Age: 40Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Enrolled in the Longitudinal Early-Onset AD Study (LEADS) and classified as amyloid-positive Early Onset Alzheimer's Disease
  • Aged between 40 and 64 years at enrollment into LEADS
  • Fluent in English
  • In good general health without other neurological disorders
  • Have a knowledgeable informant
  • Clinical Dementia Rating scale of 0.5 to 1.0 at LEADS enrollment
  • Sufficient vision, hearing, comprehension, and manual skills to participate in testing and training
Not Eligible

You will not qualify if you...

  • Access to the internet for less than 4 hours per week

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 remote baseline visit

Treatment

Duration - 14 weeks

Participants complete 14 weeks of lifestyle interventions consisting of either Cognitive Training combined with Tai Chi- Qi Gong exercise or Brain Games combined with stretching exercises.

Remote training sessions 4 to 5 times per week for cognitive devices and 2 times per week for behavioral exercises

Follow-up

Duration - 6 months post-treatment

Participants undergo assessments immediately after treatment and again at 6 months post-treatment to evaluate cognition, functioning, mood, and quality of life.

2 remote follow-up visits

Trial Site Locations

Total: 1 location

1

Indiana University

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

D

Dustin B Hammers, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

An Integrated Multifocal tDCS-EEG Protocol for Improving Cog...

Mild Cognitive Impairment (MCI)

Actively Recruiting

1 location

A Double-blind, Randomized, Placebo-controlled Phase 1b Stud...

Alzheimer Disease, Early Onset

Actively Recruiting

4 locations

A Phase 1b, Multicenter, Randomized, Placebo-Controlled, Dou...

Alzheimer Disease, Early Onset

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here